tiprankstipranks
Trending News
More News >
Takara Bio Inc. (JP:4974)
:4974
Japanese Market

Takara Bio Inc. (4974) Ratios

Compare
2 Followers

Takara Bio Inc. Ratios

JP:4974's free cash flow for Q2 2025 was ¥0.58. For the 2025 fiscal year, JP:4974's free cash flow was decreased by ¥ and operating cash flow was ¥-0.46. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.50 8.09 8.76 5.40 3.92
Quick Ratio
3.96 6.34 7.10 4.62 2.54
Cash Ratio
2.38 4.14 4.63 3.61 1.36
Solvency Ratio
-0.04 0.58 0.57 1.24 1.22
Operating Cash Flow Ratio
0.35 0.82 0.24 2.57 0.40
Short-Term Operating Cash Flow Coverage
0.00 30.28 9.51 0.00 0.00
Net Current Asset Value
¥ 26.43B¥ 48.20B¥ 51.34B¥ 60.82B¥ 48.49B
Leverage Ratios
Debt-to-Assets Ratio
0.08 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.10 <0.01 <0.01 <0.01 0.01
Debt-to-Capital Ratio
0.09 <0.01 <0.01 <0.01 0.01
Long-Term Debt-to-Capital Ratio
0.09 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.29 1.09 1.10 1.15 1.21
Debt Service Coverage Ratio
-4.11 26.25 32.30 837.50 1.11K
Interest Coverage Ratio
-1.96 113.15 130.57 855.88 1.26K
Debt to Market Cap
0.11 <0.01 <0.01 0.00 0.00
Interest Debt Per Share
85.15 9.31 8.23 8.27 8.89
Net Debt to EBITDA
-1.76 -4.38 -4.08 -2.01 -0.68
Profitability Margins
Gross Profit Margin
54.87%57.88%61.85%57.29%72.69%
EBIT Margin
-10.45%4.49%6.61%27.19%40.70%
EBITDA Margin
1.22%14.44%18.16%32.35%48.82%
Operating Profit Margin
-1.13%5.02%6.90%26.29%42.69%
Pretax Profit Margin
-10.78%4.43%6.56%27.16%40.67%
Net Profit Margin
-14.48%2.31%3.40%20.49%29.32%
Continuous Operations Profit Margin
-14.37%2.41%3.47%20.54%29.41%
Net Income Per EBT
134.27%52.18%51.88%75.44%72.09%
EBT Per EBIT
956.34%88.25%95.00%103.33%95.26%
Return on Assets (ROA)
0.45%0.83%1.20%12.39%17.15%
Return on Equity (ROE)
0.52%0.90%1.33%14.27%20.70%
Return on Capital Employed (ROCE)
1.74%1.91%2.59%17.89%29.39%
Return on Invested Capital (ROIC)
0.63%1.04%1.37%13.51%21.22%
Return on Tangible Assets
0.55%0.89%1.28%13.33%18.63%
Earnings Yield
0.61%1.05%1.27%7.67%7.36%
Efficiency Ratios
Receivables Turnover
5.03 3.21 3.86 6.28 3.80
Payables Turnover
21.11 11.48 10.76 14.37 9.44
Inventory Turnover
1.61 1.53 1.40 3.01 0.77
Fixed Asset Turnover
0.70 0.79 0.89 1.91 1.86
Asset Turnover
0.33 0.36 0.35 0.60 0.59
Working Capital Turnover Ratio
1.20 0.85 0.73 1.37 1.56
Cash Conversion Cycle
310.06 321.12 321.35 153.98 532.42
Days of Sales Outstanding
76.13 113.59 94.68 58.14 95.99
Days of Inventory Outstanding
260.48 239.31 260.60 121.24 475.10
Days of Payables Outstanding
26.55 31.78 33.93 25.40 38.68
Operating Cycle
336.61 352.91 355.28 179.39 571.09
Cash Flow Ratios
Operating Cash Flow Per Share
23.16 48.53 14.21 306.42 58.01
Free Cash Flow Per Share
-150.49 -33.44 -91.91 257.57 -46.12
CapEx Per Share
173.65 81.97 106.12 48.85 104.13
Free Cash Flow to Operating Cash Flow
-6.50 -0.69 -6.47 0.84 -0.80
Dividend Paid and CapEx Coverage Ratio
0.12 0.49 0.10 3.75 0.48
Capital Expenditure Coverage Ratio
0.13 0.59 0.13 6.27 0.56
Operating Cash Flow Coverage Ratio
0.28 5.31 1.77 37.96 6.67
Operating Cash Flow to Sales Ratio
0.06 0.13 0.04 0.47 0.10
Free Cash Flow Yield
-6.35%-4.04%-9.51%14.86%-2.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-14.75 95.69 78.60 13.03 13.60
Price-to-Sales (P/S) Ratio
2.14 2.21 2.67 2.67 3.99
Price-to-Book (P/B) Ratio
0.92 0.86 1.04 1.86 2.81
Price-to-Free Cash Flow (P/FCF) Ratio
-5.20 -24.76 -10.51 6.73 -48.59
Price-to-Operating Cash Flow Ratio
33.76 17.06 67.98 5.66 38.63
Price-to-Earnings Growth (PEG) Ratio
0.01 -3.23 -0.87 -0.67 0.13
Price-to-Fair Value
0.92 0.86 1.04 1.86 2.81
Enterprise Value Multiple
158.02 10.96 10.65 6.24 7.48
Enterprise Value
82.63B 71.26B 84.12B 157.80B 247.26B
EV to EBITDA
12.13 10.96 10.65 6.24 7.48
EV to Sales
1.80 1.58 1.93 2.02 3.65
EV to Free Cash Flow
-13.76 -17.69 -7.60 5.09 -44.52
EV to Operating Cash Flow
25.65 12.19 49.16 4.28 35.40
Tangible Book Value Per Share
653.77 895.90 861.69 858.74 721.70
Shareholders’ Equity Per Share
850.20 959.19 926.01 931.92 796.17
Tax and Other Ratios
Effective Tax Rate
-0.33 0.46 0.47 0.24 0.28
Revenue Per Share
366.02 374.03 361.29 648.94 562.21
Net Income Per Share
-53.00 8.65 12.29 132.97 164.84
Tax Burden
0.34 0.52 0.52 0.75 0.72
Interest Burden
0.92 0.99 0.99 1.00 1.00
Research & Development to Revenue
0.15 0.15 0.19 0.11 0.09
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
5.56 5.61 1.16 1.74 0.25
Currency in JPY